Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 16 de 16
Filter
1.
Exp Mol Pathol ; 92(1): 50-3, 2012 Feb.
Article in English | MEDLINE | ID: mdl-22032939

ABSTRACT

An alcohol-associated change in the serum transferrin glycoform pattern, carbohydrate-deficient transferrin (CDT), is used as a biomarker of chronic moderate to heavy alcohol consumption. Furthermore, CDT is employed as a marker of abstinence. Here, we analyzed CDT in patients with chronic excessive alcohol abuse at the beginning and during abstinence. Twenty-nine alcohol dependent patients were recruited from an in-patient abstention program. Reported drinking levels were at least 100 g/d (range up to 450 g/d; mean: 248.9±94.7 g/d) within the last month before study entry. Blood samples were drawn at the beginning and during the abstention program and the relative concentration (%CDT) of CDT was determined using ion exchange followed by immunodetermination of CDT. At study entry, 25/29 patients had a %CDT level above the established cutoff. Although CDT levels declined during abstinence in most patients, in ten patients with %CDT levels just above the cutoff at the start of the program, the CDT values remained elevated 6 weeks after cessation of drinking. Our data indicate that %CDT levels below the cutoff cannot even rule out long lasting excessive alcohol abuse. Further, measurement of %CDT should be interpreted with special care when used as a marker of alcohol abstinence.


Subject(s)
Alcoholism/blood , Alcoholism/rehabilitation , Temperance , Transferrin/analogs & derivatives , Adult , Alcohol Drinking/blood , Biomarkers/blood , Female , Humans , Male , Middle Aged , Time Factors , Transferrin/analysis
2.
Am J Pathol ; 176(3): 1433-42, 2010 Mar.
Article in English | MEDLINE | ID: mdl-20093481

ABSTRACT

Fibroblast growth factor receptor 2 isoform b (FGFR2-IIIb) is highly expressed in hepatocytes and plays an important role in liver homeostasis and regeneration. Here, we analyzed the expression and function of FGFR2-IIIb in hepatocellular carcinoma (HCC). FGFR2-IIIb expression in HCC tissues and cell lines was lower than in primary human hepatocytes and nontumorous tissue. FGFR2-IIIb-negative HCCs showed a significantly higher Ki-67 labeling index, and loss of FGFR2-IIIb expression correlated significantly with vascular invasion and more advanced tumor stages. A decrease in FGFR-2IIIb expression in HCC cell lines was not related to promoter hypermethylation. However, PCR analysis indicated that chromosomal deletion at 10q accounted for the loss of FGFR2 expression in a subset of HCC cells. FGFR2-IIIb re-expression in stable transfected HCC cell lines induced a higher basal apoptosis rate and a significantly reduced proliferation and migratory potential in vitro. In nude mice, FGFR2-IIIb re-expressing HCC cells grew significantly slower, and terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling assay revealed higher apoptosis rates. The antitumorigenic effects of FGFR2-IIIb expression in HCC cells were not affected by keratinocyte growth factor or an inhibitor of FGFR-phosphorylation, indicating that they are independent of tyrosine kinase activation. In conclusion, our data indicate that FGFR2-IIIb inhibits tumorigenicity of HCC cells. Identification of the molecular mechanisms promoting regeneration in normal tissue while suppressing malignancy may lead to novel therapeutic targets of this highly aggressive tumor.


Subject(s)
Carcinoma, Hepatocellular/genetics , Carcinoma, Hepatocellular/pathology , Liver Neoplasms/genetics , Liver Neoplasms/pathology , Receptor, Fibroblast Growth Factor, Type 2/genetics , Aged , Animals , Cell Line, Tumor , Cell Proliferation/drug effects , DNA Methylation/drug effects , DNA Methylation/genetics , Down-Regulation/drug effects , Down-Regulation/genetics , Female , Fibroblast Growth Factor 7/pharmacology , Gene Expression Regulation, Neoplastic/drug effects , Humans , Male , Mice , Middle Aged , Promoter Regions, Genetic/genetics , Protein Kinase Inhibitors/pharmacology , Pyrroles/pharmacology , Receptor, Fibroblast Growth Factor, Type 2/metabolism
3.
Ann Surg Innov Res ; 3: 13, 2009 Nov 19.
Article in English | MEDLINE | ID: mdl-19925644

ABSTRACT

The objective of the present study was to evaluate the aptitude of TRAIL gene expression for inducing apoptosis in co-cultivated T-cells. This should allow preparing a strategy for the development of a durable, allogenic skin substitute based on the induction of an immune-privileged transplant. In order to counteract the significant potential of rejection in transplanted allogenic keratinocytes, we created a murine keratinocyte cell line which expressed TRAIL through stable gene transfer. The exogenic protein was localized on the cellular surface and was not found in soluble condition as sTRAIL. Contact to TRAIL expressing cells in co-culture induced cell death in sensitive Jurkat-cells, which was further intensified by lymphocyte activation. This cytotoxic effect is due to the induction of apoptosis. We therefore assume that the de-novo expression of TRAIL in keratinocytes can trigger apoptosis in activated lymphocytes and thus prevent the rejection of keratinocytes in allogenic, immune-privileged transplants.

4.
Biochem Biophys Res Commun ; 382(2): 359-64, 2009 May 01.
Article in English | MEDLINE | ID: mdl-19285038

ABSTRACT

Cysteine-rich FGF receptor (CFR) was originally identified as a FGF2 receptor and found to be identical to Golgi complex-localized glycoprotein-1 (GLG1), also known as MG-160, and to a murine E-selectin ligand-1 (ESL-1). Although CFR is a 150-kDa integral membrane glycoprotein that is primarily located in the cis-medial Golgi complex, a substantial proportion of CFR is secreted but the underlying mechanism is unknown. CFR contains several possible furin-like proprotein convertase (PC) and matrix metalloproteinase cleavage sites. Cells expressing CFR were treated with the furin protease inhibitor decanoyl-Arg-Val-Lys-Arg-chloromethylketone (decCMK) or the MMP-inhibitor GM6001. In the presence of furin-like PC inhibitor, secretion of CFR was almost completely inhibited. Secretion was not affected by the GM6001 inhibitor. The secreted forms were further characterized by creating different mutant CFR proteins with N-terminal and C-terminal tags. Immunoblot analysis and immunofluorescence indicated, that successive endoproteolytical processing of CFR which takes place in the Golgi complex is essential for secretion. Secreted CFR bound to heparan sulphate proteoglycan (HSPG) could trap FGFs and thereby directly competing with tyrosine kinase receptors for FGF binding.


Subject(s)
Proprotein Convertases/metabolism , Protein Processing, Post-Translational , Receptors, Fibroblast Growth Factor/metabolism , Sialoglycoproteins/metabolism , Amino Acid Chloromethyl Ketones/pharmacology , Animals , COS Cells , Chickens , Chlorocebus aethiops , Dipeptides/pharmacology , Fibroblast Growth Factors/metabolism , Furin/antagonists & inhibitors , Furin/metabolism , Humans , Metalloendopeptidases/antagonists & inhibitors , Mutation , Proprotein Convertases/antagonists & inhibitors , Receptors, Fibroblast Growth Factor/genetics , Sialoglycoproteins/genetics
5.
Oncol Rep ; 21(2): 357-62, 2009 Feb.
Article in English | MEDLINE | ID: mdl-19148508

ABSTRACT

Leukocytes and tumor cells use E-selectin binding ligands to attach to activated endothelial cells expressing E-selectin during inflammation or metastasis. The cysteine-rich fibroblast growth factor receptor (CFR) represents the main E-selectin ligand (ESL-1) on granulocytes and its expression is exclusively modified by alpha(1,3)-fucosyltransferases IV or VII (FucT4 and FucT7). Hepatic stellate cells (HSC) are pericytes of liver sinusoidal endothelial cells. The activation of HSC and transdifferentiation into a myofibroblastic phenotype is involved in the repair of liver tissue injury, liver regeneration and angiogenesis of liver metastases. In the present study, we demonstrated that HSC expressed CFR together with FucT7 and exhibited a functional E-selectin binding activity on their cell surface. Since HSC appear to be oxygen-sensing cells, the expression of E-selectin binding activity was analyzed in HSC under a hypoxic atmosphere. While the expression of the glycoprotein CFR was unaffected by hypoxia, the cell-associated E-selectin binding activity decreased. However, under the same conditions, mRNA expression of the modifying enzyme FucT7 increased. The loss of E-selectin binding activity, therefore, appears to be neither the result of a reduced expression of the modifying transferase nor the expression of the backbone glycoprotein. After the transient transfection of HSC with CFR cDNA, the E-selectin binding activity (ESL-1) was efficiently released into the supernatant. Therefore, we hypothesize that under hypoxia, ESL-1 is shed from activated HSC. Our findings provide a novel perspective on the function of HSC in liver metastasis and inflammatory liver diseases.


Subject(s)
Chemotaxis, Leukocyte/physiology , Hepatic Stellate Cells/metabolism , Liver Neoplasms/metabolism , Receptors, Fibroblast Growth Factor/biosynthesis , Sialoglycoproteins/biosynthesis , Animals , Blotting, Northern , Blotting, Western , Cell Hypoxia , E-Selectin/genetics , E-Selectin/metabolism , Fluorescent Antibody Technique , Fucosyltransferases/genetics , Fucosyltransferases/metabolism , Gene Expression , Humans , Liver Neoplasms/secondary , Male , Neoplasm Metastasis/pathology , RNA, Messenger/analysis , Rats , Rats, Sprague-Dawley , Reverse Transcriptase Polymerase Chain Reaction
6.
Cancer Sci ; 100(4): 646-53, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19175606

ABSTRACT

Liver cirrhosis is the main risk factor for the development of hepatocellular carcinoma (HCC). Activated hepatic stellate cells (HSC) are the effector cells of hepatic fibrosis and also infiltrate the HCC stroma where they might play a critical role in HCC progression. Here we aimed to analyze the effects of activated HSC on the proliferation and growth of HCC cell lines in vitro and in vivo. Conditioned media (CM) collected from HSC significantly induced proliferation and migration of HCC cells cultured in monolayers. In a 3-dimensional spheroid coculture system, HSC promoted HCC growth and diminished the extent of central necrosis. In accordance, in vivo simultaneous implantation of HSC and HCC cells into nude mice promoted tumor growth and invasiveness, and inhibited necrosis formation. As potential mechanism of the tumorigenic effects of HSC we identified activation of NFkappaB and extracellular-regulated kinase (ERK) in HCC cells, two signaling cascades that play a crucial role in HCC progression. In summary, our data indicate that stromal HSC promotes HCC progression and suggest the HSC-HCC interaction as an interesting tumor differentiation-independent target for therapy of this highly aggressive cancer.


Subject(s)
Carcinoma, Hepatocellular/pathology , Cell Movement/drug effects , Cell Proliferation/drug effects , Culture Media, Conditioned/pharmacology , Hepatic Stellate Cells/metabolism , Liver Neoplasms/pathology , Animals , Cell Line, Tumor , Coculture Techniques , Enzyme Activation , Humans , Mice , Mice, Nude , Mitogen-Activated Protein Kinase 1/metabolism , Mitogen-Activated Protein Kinase 3/metabolism , NF-kappa B/metabolism , Neurotrophin 3/genetics , Neurotrophin 3/metabolism , Organ Culture Techniques , RNA, Messenger/analysis , Xenograft Model Antitumor Assays
7.
J Gastroenterol Hepatol ; 24(4): 558-63, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19067777

ABSTRACT

BACKGROUND: Adiponectin is a circulating protein with hepatoprotective effects. AIMS: To study the relationship of excessive alcohol consumption and serum adiponectin levels (SAL). PATIENTS AND METHODS: The SAL were determined in (i) heavy drinkers without advanced liver damage during the course of alcohol withdrawal, (ii) patients with chronic hepatitis C virus (HCV) infection, (iii) patients with alcohol-associated cirrhosis, and (iv) healthy volunteers that consumed excessive amounts of alcohol for only a short period of time. Further, primary human hepatocytes (PHH) and adipocytes were incubated in vitro with alcohol or serum of patients. RESULTS: Patients with chronic alcohol consumption had significantly higher SAL than HCV-patients with comparable degrees of liver damage. In alcoholics, but not in HCV patients, SAL positively correlated with serum levels of aminotransferases. Further, SAL correlated with the amount of alcohol consumption but declined during the course of alcohol abstinence. After short-term excessive alcohol consumption SAL were not elevated in healthy individuals. Adiponectin mRNA was detectable in adipocytes but not in hepatocytes, and alcohol failed to induce adiponectin in both cell types. In contrast, serum of active drinkers induced adiponectin expression in adipocytes while serum from the same individuals collected after alcohol withdrawal had no effect. CONCLUSIONS: Alcohol exhibits a specific effect on SAL that is dose and time dependent, and correlates with the degree of hepatic damage. Alcohol does not seem to affect adiponectin expression directly in adipocytes but potentially via mediators systemically released as a result of the chronic alcohol intake.


Subject(s)
Alcohol Drinking/blood , Alcoholism/blood , Hepatitis C, Chronic/blood , Liver Cirrhosis, Alcoholic/etiology , Liver Cirrhosis/blood , Liver/pathology , Substance Withdrawal Syndrome/blood , 3T3-L1 Cells , Adipocytes/drug effects , Adipocytes/metabolism , Adiponectin/blood , Adiponectin/genetics , Adult , Alanine Transaminase/blood , Alcohol Drinking/pathology , Alcoholism/complications , Alcoholism/pathology , Alcoholism/therapy , Animals , Aspartate Aminotransferases/blood , Biomarkers/blood , Dose-Response Relationship, Drug , Ethanol/toxicity , Female , Hepatitis C, Chronic/complications , Hepatitis C, Chronic/pathology , Hepatocytes/drug effects , Hepatocytes/metabolism , Humans , Liver/enzymology , Liver/virology , Liver Cirrhosis/pathology , Liver Cirrhosis/virology , Liver Cirrhosis, Alcoholic/blood , Liver Cirrhosis, Alcoholic/pathology , Male , Mice , Middle Aged , RNA, Messenger/metabolism , Substance Withdrawal Syndrome/pathology , Substance Withdrawal Syndrome/therapy , Time Factors , Up-Regulation
8.
Thromb Haemost ; 98(6): 1329-34, 2007 Dec.
Article in English | MEDLINE | ID: mdl-18064332

ABSTRACT

Low-response to the P2Y12 adenosine diphosphate (ADP)-receptor antagonist clopidogrel was suggested to correspond to a higher incidence of stent thrombosis (ST). This prospective observational study assessed the capability of two platelet function assays, e.g. direct measurement of the phosphorylation status of vasodilator-stimulated phosphoprotein (VASP) and ADP-induced platelet aggregation for definition of the individual risk to develop ST. Ninety-nine patients with an elevated high risk to develop ST were enrolled. All patients received a dual antiplatelet therapy consisting of 100 mg aspirin and 75 mg clopidogrel during an observation period of six months. Flow cytometry of VASP phosphorylation and densitometrically-determined measurement of ADP-induced platelet aggregation was performed 72-96 hours after stent implantation. These data were related to angiographically confirmed ST. Nine patients suffered from angiographically confirmed ST (9.1%). The meanVASP-platelet reactivity indices (VASP-PRI) and values for ADP-induced platelet aggregation in the ST group were significantly higher (60.8 +/- 13.0 and 60.9 +/- 13.1, respectively) compared to patients without ST (41.3 +/- 14.0 and 50.8 +/- 14.4, P < 0.001 vs. 0.048, respectively). There was a fair correlation between both methods using non-linear regression analysis (r = 0.332). In a multivariate analysis, VASP was the only independent predictor of ST and was superior to previously identified angiographic parameters. Receiver- operator characteristic (ROC) curve analysis revealed a cut-off value for VASP-PRI of <48% to be associated with low risk of ST. In conclusion, determination of VASP phosphorylation is superior to conventional platelet aggregometry and angiographic parameters for assessing the risk of ST. Patients with a VASP-PRI >48% seem to have a significantly increased risk.


Subject(s)
Angioplasty, Balloon, Coronary/adverse effects , Cell Adhesion Molecules/blood , Microfilament Proteins/blood , Phosphoproteins/blood , Platelet Aggregation Inhibitors/therapeutic use , Platelet Aggregation , Platelet Function Tests , Stents , Thrombosis/diagnosis , Adenosine Diphosphate , Aged , Angioplasty, Balloon, Coronary/instrumentation , Aspirin/therapeutic use , Clopidogrel , Coronary Angiography , Drug Therapy, Combination , Female , Flow Cytometry , Humans , Male , Middle Aged , Phosphorylation , Platelet Function Tests/methods , Predictive Value of Tests , Prospective Studies , ROC Curve , Reproducibility of Results , Research Design , Risk Assessment , Risk Factors , Sensitivity and Specificity , Thrombosis/blood , Thrombosis/diagnostic imaging , Thrombosis/etiology , Thrombosis/prevention & control , Ticlopidine/analogs & derivatives , Ticlopidine/therapeutic use , Time Factors , Treatment Outcome
9.
Biochem Biophys Res Commun ; 361(2): 335-41, 2007 Sep 21.
Article in English | MEDLINE | ID: mdl-17662249

ABSTRACT

Hepatic injury and regeneration of the liver are associated with activation of hepatic stellate cells (HSC). Fibroblast growth factors (FGFs) and their receptors are important regulators of repair in various tissues. HSC express FGFR3IIIc as well as FGFGR4 and different spliced FGFR1IIIc and FGFR2IIIc isoforms which differ in the presence or absence of the acid box and of the first Ig-like domain. Expression of FGF9, known to be capable to activate the HSC FGFR2/3-isoforms, was increased in HSC in liver slice cultures after exposition to carbon tetrachloride, as an acute liver injury model. FGF9 significantly stimulated 3-H thymidine incorporation of hepatocytes, but failed to induce DNA synthesis in HSC despite the fact that FGF9 induced a sustained activation of extracellular signal-related kinases (ERK) 1/2. FGF9 induced an increased phosphorylation of Tyr436 of the fibroblast growth factor receptor substrate (FRS) 2, while phosphorylation of Tyr196 which is required for efficient Grb2 recruitment remained unchanged. Our findings suggest that HSC FGF9 provide a paracrine mitogenic signal to hepatocytes during acute liver injury, while the autocrine FGF9 signaling appears to be not sufficient to induce cell proliferation.


Subject(s)
Fibroblast Growth Factor 9/genetics , Fibroblast Growth Factor 9/metabolism , Hepatocytes/metabolism , Liver Diseases/metabolism , Animals , COS Cells , Cells, Cultured , Chemical and Drug Induced Liver Injury , Chlorocebus aethiops , DNA/biosynthesis , Enzyme Activation , Fibroblast Growth Factor 2/metabolism , Hepatocytes/enzymology , Humans , In Vitro Techniques , Male , Mitogen-Activated Protein Kinase 1/metabolism , Mitogen-Activated Protein Kinase 3/metabolism , Mitogens/metabolism , Protein Isoforms/genetics , Protein Isoforms/metabolism , Rats , Rats, Sprague-Dawley , Receptors, Fibroblast Growth Factor/genetics , Receptors, Fibroblast Growth Factor/metabolism , Up-Regulation/genetics
10.
Clin Chem Lab Med ; 44(4): 420-2, 2006.
Article in English | MEDLINE | ID: mdl-16599835

ABSTRACT

BACKGROUND: The CA 125 antigen is a large (200-1000 kDa) glycoprotein, present within normal and benign ovarian tissue. We evaluated the analytical performance of the newly available Beckman Coulter OV-Monitor (CA 125 antigen) immunoassay on the Beckman Coulter UniCel DxI 800 analyzer. METHODS: The evaluation was performed according to NCCLS recommendations. RESULTS: The lowest level of CA 125 antigen detectable was 0.374 U/mL. Serial dilution of two pooled CA 125 antigen-rich samples provided a linear response (p<0.0001). For total CV% the following results were obtained: pool sera, 11.7 U/mL (2.70%), 56.3 U/mL (2.41%), 108.43 U/mL (2.31%); and QC sera, 29.4 U/mL (2.57%), 101.1 U/mL (3.26%). Comparison of the OV-Monitor on the UniCel DxI 800 showed linear regression values of r=0.961 vs. the Bayer ADVIA Centaur system and r=0.981 vs. the Abbott AxSYM system. CONCLUSION: Considering the limited number of serum samples analyzed, our data indicate that the Beckman Coulter OV-Monitor immunoassay has excellent analytical performance and shows satisfactory correlation with automated immunoassays on the Abbott AxSYM and Bayer ADVIA Centaur systems. It is easy to perform, accurate and suitable for measurements in routine clinical laboratories.


Subject(s)
Immunoassay/instrumentation , Antigens, Tumor-Associated, Carbohydrate/analysis , CA-125 Antigen/analysis , Humans , Immunoassay/standards , Reproducibility of Results , Sensitivity and Specificity
11.
Lab Hematol ; 12(1): 15-31, 2006.
Article in English | MEDLINE | ID: mdl-16513543

ABSTRACT

This study presents the results of performance evaluations of the Cell-Dyn Sapphire (CD-Sapphire) undertaken by 3 study sites in Europe. These studies focused on the routine blood count analyses with specific consideration of precision and imprecision, linearity, inter-instrument correlations, and white blood cell differential and flagging efficiencies. The CD-Sapphire was compared to the Cell-Dyn CD4000, Bayer Advia 120, Beckman Coulter GenS, and reference microscopy.


Subject(s)
Leukocytes/cytology , Reticulocytes/cytology , Europe , Humans , Leukocyte Count/instrumentation , Leukocyte Count/methods , Leukocyte Count/standards , Reference Standards , Reproducibility of Results , Reticulocyte Count/instrumentation , Reticulocyte Count/methods , Reticulocyte Count/standards
12.
Clin Biochem ; 39(1): 39-45, 2006 Jan.
Article in English | MEDLINE | ID: mdl-16321365

ABSTRACT

OBJECTIVES: Progression of liver fibrosis to cirrhosis is a dire consequence of chronic liver diseases (CLD). Nepsilon-(carboxymethyl)lysine (CML)-modified advanced glycation end products (AGEs) in patients with CLD could reflect the degree of severity of the disease. DESIGN AND METHODS: In 110 patients with CLD and 124 healthy controls, CML serum levels and their diagnostic sensitivity and specificity were determined and compared to hyaluronan (HA). RESULTS: Serum levels of CML were significantly affected by the stage of liver cirrhosis and were closely associated with liver function capacity. CML correlated positively with HA (r = 0.639, P < 0.0001). In ROC analysis, the diagnostic sensitivity and specificity in distinguishing healthy controls from liver disease patients for CML (AUC 0.908; 95%-CI 0.863-0.942, cut-off 640 ng/mL, sensitivity 74.5% and specificity 97.6%) resembled HA (AUC 0.948; 95%-CI 0.907-0.974; cut-off 50 ng/mL, sensitivity 80.7% and specificity 97.9%). The combination of CML and HA shows an AUC of 0.932; 95%-CI 0.888-0.962; sensitivity 82.6%; and specificity 95.8%. CONCLUSIONS: Our data suggest that serum levels of CML could provide a supplementary diagnostic marker for advanced stages of liver cirrhosis. However, the quality of interaction needs further investigation.


Subject(s)
Glycation End Products, Advanced/metabolism , Liver Cirrhosis/diagnosis , Lysine/analogs & derivatives , Adolescent , Adult , Aged , Chronic Disease , Female , Humans , Hyaluronic Acid/blood , Liver Cirrhosis/metabolism , Lysine/blood , Lysine/metabolism , Male , Middle Aged
13.
Biochem Biophys Res Commun ; 338(2): 1248-55, 2005 Dec 16.
Article in English | MEDLINE | ID: mdl-16263090

ABSTRACT

The secreted isoform of fibroblast growth factor 3 (FGF3) induces a mitogenic cell response, while the nuclear form inhibits cell proliferation. Recently, we identified a nucleolar FGF3-binding protein which is implicated in processing of pre-rRNA as a possible target of nuclear FGF3 signalling. Here, we report a second candidate protein identified by a yeast two-hybrid screen for nuclear FGF3 action, ribosomal protein S2, rpS2. Recombinant rpS2 binds to in vitro translated FGF3 and to nuclear FGF3 extracted from transfected COS-1 cells. Characterization of the FGF3 binding domain of rpS2 showed that both the Arg-Gly-rich N-terminal region and a short carboxyl-terminal sequence of rpS2 are necessary for FGF3 binding. Mapping the S2 binding domains of FGF3 revealed that these domains are important for both NoBP and rpS2 interaction. Transient co-expression of rpS2 and nuclear FGF3 resulted in a reduced nucleolar localization of the FGF. These findings suggest that the nuclear form of FGF3 inhibits cell proliferation by interfering with ribosomal biogenesis.


Subject(s)
Fibroblast Growth Factor 3/chemistry , Fibroblast Growth Factor 3/metabolism , Ribosomal Proteins/chemistry , Ribosomal Proteins/metabolism , Subcellular Fractions/metabolism , Amino Acid Sequence , Animals , Binding Sites , COS Cells , Chlorocebus aethiops , Humans , Molecular Sequence Data , Protein Binding , Protein Interaction Mapping
14.
Clin Chem ; 51(12): 2341-7, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16214828

ABSTRACT

BACKGROUND: Single-center trials have shown that monocytic HLA-DR is a good marker for monitoring the severity of temporary immunodepression after trauma, major surgery, or sepsis. A new test for measuring monocytic HLA-DR is now available. METHODS: We evaluated a new test reagent set for monocytic HLA-DR expression (BD Quantibritetrade mark HLA-DR/Monocyte reagent; Becton Dickinson) in single-laboratory and interlaboratory experiments, assessing preanalytical handling, lyse-no-wash (LNW) vs lyse-wash (LW) values, reference values, and the effect of use of different flow cytometers and different instrument settings on test variance. RESULTS: For preanalytical handling, EDTA anticoagulation, storage on ice as soon as possible, and staining within 4 h after blood collection gave results comparable to values obtained for samples analyzed immediately after collection (mean increase of approximately 4% in monocytic HLA-DR). Comparison of LNW and LW revealed slightly higher results for LNW ( approximately 18% higher for LNW compared with LW; r = 0.982). Comparison of different flow cytometers and instrument settings gave CVs <4%, demonstrating the independence of the test from these variables and suggesting that this method qualifies as a standardized test. CV values from the interlaboratory comparison ranged from 15% (blood sample unprocessed before transport) to 25% (stained and fixed before transport). CONCLUSIONS: For the BD Quantibrite HLA-DR/Monocyte test, preanalytical handling is standardized. Single-laboratory results demonstrated the independence of this test from flow cytometer and instrument settings. Interlaboratory results showed greater variance than single-laboratory values. This interlaboratory variance was partly attributable to the influence of transport and can be reduced by optimization of transport conditions.


Subject(s)
Flow Cytometry/methods , Gene Expression Regulation , HLA-DR Antigens/analysis , HLA-DR Antigens/immunology , Immune Tolerance/immunology , Monocytes/immunology , Monocytes/metabolism , Humans , Monocytes/drug effects
15.
J Biol Chem ; 277(36): 32760-7, 2002 Sep 06.
Article in English | MEDLINE | ID: mdl-12084721

ABSTRACT

NIH3T3 cells transformed by mouse FGF3-cDNA (DMI cells) selected for their ability to grow as anchorage-independent colonies in soft agar and in defined medium lacking growth factors exhibit a highly transformed phenotype. We have used dominant negative (DN) fibroblast growth factor (FGF) receptor 2 (FGFR2) isoforms to block the FGF response in DMI cells. When the DN-FGFR was expressed in DMI cells, their transformed phenotype can be reverted. The truncated FGFR2(IIIb), the high affinity FGFR for FGF3, is significantly more efficient at reverting the transformed phenotype as the IIIc isoform, reaffirming the notion that the affinity of the ligand to the DN-FGFR2 isoform determines the effect. Heparin or heparan sulfate displaces FGF3 from binding sites on the cell surface inhibiting the growth of DMI cells and reverts the transformed phenotype (). However, the presence of heparin is necessary to induce a mitogenic response in NIH3T3 cells when stimulated with soluble purified mouse FGF3. We have investigated the importance of cell surface binding of FGF3 for its ability to transform NIH3T3 cells by creating an FGF3 mutant anchored to the membrane via glycosylphosphatidylinositol (GPI). The GPI anchor renders the cell surface association of FGF3 independent from binding to heparan sulfate-proteoglycan of the cell surface membrane. Attachment of a GPI anchor to FGF3 also confers a much higher transforming potential to the growth factor. Even more, the purified GPI-attached FGF3 is as much transforming as the secreted protein acting in an autocrine mode. Because NIH3T3 cells do not express the high affinity tyrosine kinase FGF receptors for FGF3, these findings suggest that FGF3 attached to GPI-linked heparan sulfate-proteoglycan may have a broader biological activity as when bound to transmembrane or soluble heparan sulfate-proteoglycan.


Subject(s)
Fibroblast Growth Factors/metabolism , Fibroblast Growth Factors/physiology , Phospholipids/metabolism , Proto-Oncogene Proteins/metabolism , Proto-Oncogene Proteins/physiology , 3T3 Cells , Amino Acid Sequence , Animals , Blotting, Northern , COS Cells , Cell Line , Cell Membrane/metabolism , Fibroblast Growth Factor 3 , Fibroblast Growth Factors/chemistry , Fibroblasts/metabolism , Genes, Dominant , Heparin/pharmacology , Heparitin Sulfate/pharmacology , Immunoblotting , Iodine/metabolism , Lactoperoxidase/metabolism , Ligands , Mice , Microscopy, Fluorescence , Mitogens/metabolism , Molecular Sequence Data , Mutation , Plasmids/metabolism , Precipitin Tests , Protein Binding , Protein Isoforms , Protein Structure, Tertiary , Proto-Oncogene Proteins/chemistry , Proto-Oncogene Proteins p21(ras)/metabolism , Transfection
16.
Development ; 129(9): 2099-108, 2002 May.
Article in English | MEDLINE | ID: mdl-11959820

ABSTRACT

Fgf3 has long been implicated in otic placode induction and early development of the otocyst; however, the results of experiments in mouse and chick embryos to determine its function have proved to be conflicting. In this study, we determined fgf3 expression in relation to otic development in the zebrafish and used antisense morpholino oligonucleotides to inhibit Fgf3 translation. Successful knockdown of Fgf3 protein was demonstrated and this resulted in a reduction of otocyst size together with reduction in expression of early markers of the otic placode. fgf3 is co-expressed with fgf8 in the hindbrain prior to otic induction and, strikingly, when Fgf3 morpholinos were co-injected together with Fgf8 morpholinos, a significant number of embryos failed to form otocysts. These effects were made manifest at early stages of otic development by an absence of early placode markers (pax2.1 and dlx3) but were not accompanied by effects on cell division or death. The temporal requirement for Fgf signalling was established as being between 60% epiboly and tailbud stages using the Fgf receptor inhibitor SU5402. However, the earliest molecular event in induction of the otic territory, pax8 expression, did not require Fgf signalling, indicating an inductive event upstream of signalling by Fgf3 and Fgf8. We propose that Fgf3 and Fgf8 are required together for formation of the otic placode and act during the earliest stages of its induction.


Subject(s)
Ear, Inner/embryology , Fibroblast Growth Factors/physiology , Proto-Oncogene Proteins/physiology , Zebrafish Proteins , Zebrafish/embryology , Zebrafish/physiology , Animals , Apoptosis , Base Sequence , Cell Division , Chick Embryo , Ear, Inner/abnormalities , Embryonic Induction/drug effects , Embryonic Induction/genetics , Embryonic Induction/physiology , Fibroblast Growth Factor 3 , Fibroblast Growth Factor 8 , Fibroblast Growth Factors/antagonists & inhibitors , Fibroblast Growth Factors/genetics , Gene Expression Regulation, Developmental , In Situ Hybridization , Mice , Oligodeoxyribonucleotides, Antisense/genetics , Oligodeoxyribonucleotides, Antisense/pharmacology , Proto-Oncogene Proteins/antagonists & inhibitors , Proto-Oncogene Proteins/genetics , RNA, Messenger/genetics , RNA, Messenger/metabolism , Signal Transduction , Zebrafish/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...